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Abstract
The immunological mechanisms involved in maintenance of an
        asymptomatic microfilaremic state (MF) in patients with lym-
phatic filariasis remain undefined. MF patients have impaired
filarial antigen ( Ag)-specific lymphocyte proliferation and de-
creased frequencies (Fo) of Ag-specific T cells, and yet ele-
vated serum IgE and antifilarial IgG4. To investigate the mech-
anism of Ag-specific anergy in MF patients in contrast to ami-
crofilaremic individuals with chronic lymphatic obstruction
(CP), the Fo Ag-specific lymphocytes from peripheral blood
mononuclear cells secreting either IL-4 or IFN- g were assessed
by filter spot enzyme-linked immunosorbent assay, and IL-10
and transforming growth factor-ß (TGF-ß) mRNA transcript
levels were assessed by a semiquantitative reverse transcrip-
tase polymerase chain reaction technique. The Fo of filaria-
specific IL-4-secreting lymphocytes were equivalent in both
MF (geometric mean [GM] = 1:11,700) and CP (GM
= 1:29,300 P =0.08), whereas the Fo of IFN- g -secreting lym-
phocytes were lower in MF (GM = 139,300) than in CP (GM
= 1:4,200, P < 0.01). When the ratio of IL-4/IFN- g (T helper
type 2 [ Th2]/Th1 )-secreting cells was examined, MF subjects
showed a predominant Th2 response (8:1) compared with a
Th1 response in CP individuals (1:4). mRNA transcript levels
of IL-10 were also significantly elevated in MF compared with
CP individuals (P < 0.01). Further, IL-10 and TGF-ß were
shown to have a role in modulating theAg-specific anergy
at neutralizing anti-IL-10 or anti-
TGF-ß significantly enhanced lymphocyte proliferation re-
sponse (by 220-1,300%) to filarial Ags in MF individuals.
These findings demonstrate that MF subjects respond to para-
site antigen by producing a set of suppressive cytokines that
may facilitate persistence of the parasite within humans while
producing little clinical disease. ( J. Clin. Invest. 1993.
92:1667-1673.) Key words: lymphatic filariasis • tolerance • T
helper subsets • IL-10 • ELISPOT
Introduction
Address correspondence to Dr. Christopher L. King, Division of Geo-
graphic Medicine, Case Western Reserve University School of Medi-
cine, 2109 Adelbert Road, Cleveland, OH 44106-4983
Receivedfor publication 30 November 1992 and in revisedform 11
May 1993.
The Journal of Clinical Investigation, Inc.
Volume 92, October 1993, 1667-1673
tions to both brugian and bancroftian filariasis infections range
from those of asymptomatic individuals with circulating mi-
crofilariae to others who exhibit chronic lymphedema and oc-
casionally pulmonary symptoms (tropical pulmonary eosino-
philia) but have no circulating microfilariae (2). This breadth
of host reaction to infection may reflect the nature of different
individuals’ immune response to filarial infection (2, 3 ). For
xample, asymptomatic microfilaremia (MF)1 s thought to
result from parasite-specific “immune hyporesponsiveness” by
the host, thereby allowing the microfilariae to persist in the
circulation (3-5). This hypothesis has been supported by ob-
servations of selectively impaired T and B cell responses to
filarial antigens ( Ags) among MF subjects ( 3- 11 ), but the Ag-
specific anergy does not extend to all immune responses in MF
individuals. as frequencies of polyclonal IgE- and lgG4-secret-
ing lymphocytes (12) and serum antifilarial IgE and lgG4 lev-
els are usually elevated (9, 13). In contrast, strong filarial Ag-
driven-T and B cell responses are observed among amicrofilare-
mic individuals with chronic lymphatic obstruction (CP).
The mechanisms underlying the apparent immunological
hyporeactivity in MF patients are poorly understood. Previous
studies in patients with brugian filariasis have suggested active
suppression by either monocytes (8) or suppressor CD8+ T
lymphocytes (7). Similar studies with PBMC from persons
i  Wuchereria bancrofti infection have failed to identify such
suppressor cell populations (11, 14). Furthermore, the obser-
vation that PBMC from MF patients with bancroftian filariasis
did not produce parasite-specific antibody in response to either
parasite Ag or the T cell-dependent B cell mitogen, PWM
(14), suggested that MF subjects may, in fact, lack Ag-respon-
sive T cells. Indeed, we recently reported that MF subjects ap-
pear to have significantly reduced frequencies (Fo) of filarial
Ag-specific T cells, estimated by limiting dilution analysis,
compared with individuals with CP that approached that of
normal uninfected individuals ( 12). However, in the limiting
dilution analysis, we observed that cultures with fewer lympho-
cytes often had similar, and sometimes even greater, numbers
of cells capable of proliferating to filarial Ags than did cultures
seeded with larger numbers of T cells. This observation sug-
gested that several interacting populations of Ag-reactive
CD4+ cells might exist and could modulate the response of
other cells to parasite antigens. In addition, these studies high-
lighted a limitation of standard limiting dilution analysis since
lymphocyte proliferation represents a late T cell response that
may be influenced by cross-regulatory molecules such as IL- 10,
TGF- b, or IFN- g ( 15-17). Furthermore, T cells may secrete
1. Abbreviations used in this paper: Ag, antigen; BmA, Brugia malayi
filarial antigen; CP, chronic lymphatic obstruction; ELISPOT, filter
spot-ELISA; Fo, frequencies: MF, microfilaremia; PPD, purified Pro-
tein derivative.
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cytokines (eg. IL-4 and IL-5) rather than proliferate strongly
in response to antigens. Thus, the present study evaluated T
cell responses to parasite Ags by analysis of cytokine produc-
tion by individual peripheral blood-derived lymphocytes in
filarial infected individuals.
In the current study we therefore determined: (a) whether
MF subjects had lymphocytes capable of responding to parasite
Ag, as determined by cytokine secretion of individual T cells
 using a filter immunoplaque assay; (b) whether different pat-
terns of cytokine production (e.g., IFN- g, vs. IL-4) are pro-
produced by individual lymphocytes from MF vs. CP subjects: and
(a) whether the “impaired” T cell proliferation characteristi-
cally seen in in MF individuals results from active suppression by
the production of additional cytokines such as IL- 10 or TGF-ß.
Study population. 29 adult volunteers living in the area of Madras,
India, where bancroftian filariasis is endemic, were studied. Clinical
history, physical examination, and PBMC were obtained from each
study participant. Microfilariae were enumerated by filtration of 3 ml
of nocturnally collected blood through a polycarbonate filter (Nucle-
pore Co ., Pleasanton, CA) ( 18). Additionally, five normal North Amer-
ican individuals (three females and two males) between 30 and 41 yr of
age were studied as controls. Not all patients were studied with all of the
assays. Selection was based only on the availability of patients for
stndy.
Antigens and mitogens. Brugia malayi fil rial antigen ( BmA) was
prepared as the saline extract of adult-stage parasites (9). PWM
(GIBCO BRL, Gaithersburg, MD) and the mycobacterial Ag, purified
protein derivative (PPD) (Connaught Labs, Willowdate, Ontario,
Canada), were used in parallel cultures.
Isolation of PBMC. All studies were performed on fresh PBMC
separated by Ficoll-diatrizoate gradient centrifugation ( 19) from hepa-
riuized venous blood.
ELISA for parasite-spectific IgG and IgE. The ELISA for parasite-
specific IgG and a solid-phase RIA for IgE were performed with BmA
antigen exactly as described previously ( 14, 20).
Filter spot-ELISA (ELISPOT). ELISPOTs to determine the fre-
quency of specific cytokine-producing lymphocytes were performed as
described previously (21). For all assays, PBMC were used with the
antigens (BmA or PPD) or with a combination of 50 ng/ml phorbol
12-myristate 13-acetate ( PMA) and 1 µg/ml ionomycin. These mito-
gens were used together because they produced maximal IL-4/IL-5
synthesis compared with other mitogenic stimuli tested (our personal
observations).
Analysis of cytokine mRNA. PBMC were cultured at 3 X 106 cells/
ml in 1-ml cultures. After 12 and 48 h. PBMC were placed directly into
RNAzol B (Tel-Test, Friendswood, TX) and stored at –70°C until use.
RNA isolation was performed as described (22 ). Cytokine transcript
levels there measured using a modification of a semiquantitative re-
verse transcriptase PCR technique previously described (15, 23).
Briefly 1 µg of total RNA was reversed transcribed using Moloney
murine leukemia virus reverse transcriptase (GIBCO BRL) in a 50-µl
reaction. The reaction mixture was then diluted 1:4, and 10 µl of di-
luted product was used for specific amplification of cytokine mRNA
using Taq DNA polymerase (Promega Biotec, Madison, WI). PCR
products were separated on a 1% agarose gel and transferred to a Hy-
bond N+ membrane (Amersham International, Amersham. UK) us-
ing standard blotting techniques. Southern transfers were subsequently
probed with internal cytokine-specific oligonucleotides and visualized
using the enhanced chemiluminescence detection system ( Amersham
International). Autoradiographs were scanned with a scanner (model
600ZS; Microtek, Torrance, CA). PCR reaction conditions were
strictly defined for each cytokine such that a log-linear relationship was
obtained betweenthe amount of specific cytokine mRNA and the sig-
nal density of the probed PCR product in the detection systems. The
amount of cytokine-specific mRNA in a sample was determined by
comparison of the signal density of the probed PCR product with that
of standard curve generated by simultaneous amplification and prob-
ing of step-wise dilutions of reverse transcribed product for known
amounts of mRSA. To control for the relative amount of products
reverse transcribed and to assess the amount of mRNA in each sample,
concurrent measurement of mRNA for the constitutively expressed
gene hypoxanthine-quanine phosphoribosyl transferase (HPRT) was
made. The oligonucleotide sequences for HPRT, IL-10, and TGF-ß
used have been previously described (24).
Proliferation assays. PBMC ( 106/ml) were cultured in round-bot-
tomed microtiter plates in 0.2 ml of C-RPMI 1640 supplemented with
gentamicin (80 µg/ml), Hepes (25 mM), and 10% human AB serum.
Media (control), BmA, PPD, or PWM were added to the wells. Cul-
tures were performed in quadruplicate or sextuplicate and maintained
in a humidified atmosphere with 5% CO2 at 37°C. After 6 d 20µl of
C-RPMI containing 1 µCi [3H] thymidine (New England Nuclear,
Boston, MA j was added to the cultures that were then incubated for an
additional 16 h before the cells were collected on glass filters with a cell
harvester (Skatron Inc., Sterling, VA). Thymidine incorporation was
measured by liquid scintillation spectroscopy (Pharmacia LKB Nu-
clear Inc., Uppsala. Sweden).
eutralising anticytokine antibodies. Neutralizing anticytokine an-    
tibodies (or appropriate control antibodies) were used as follows: (a)
anti-IL-10 (JES 3-9D7 [53]) at 10 µg/ml (irrelevant rat mAb of the
IgG1 isotype was used as a control); (b) anti-TGF-ß polyvalent
chicken Ab and appropriate control antiserum at 5 µg/ml (AB-101-
NA; R&D Systems. Minneapolis, MN); (c) anti-IL-2 polyvalent rabbit
serum (1:200 dilution) with preimmune sera control; and (d) anti-
IFS-y polyvalent rabbit serum ( 1:200 dilution) with preimmune sera
control as previously described (25).
Data analysis. Means were compared using Student’s t test with
logarithmically transformed data. The Fisher’s exact test was used to
examine the effect of anti-IL-10 and anti-TGF-8 Abs on lymphocyte
proliferation shown in Fig. 1.
Results
Study subjects. Patients were selected based on their availabil-
ity and classified into two groups. Asymptomatic individuals
with circulating MT and patients without MF but who had a
history of lymphangitis or lymphadenitis evidence of
c ronic lymphatic obstruction (CP) in one or more limbs were
studied. The CP patients were of both sexes and older (median
age. 40 yr) than the MF patients (median age, 30 yr). Serum
filaria-specific IgG4 and polyclonal IgE levels were markedly
elevated in MF individuals and significantly higher than
among CP subjects (Table I). In healthy uninfected North
American individuals specific IgG4 is undetectable and polyclo-
nal IgE is <450 ng/ml. In contrast. total serum IgG levels were
significantly lower among MF vs. CP subjects (Table I). Filar-
ial-specific serum IgG levels (MF, geometric mean [GM]
= 442 U/ml: CP, GM = 585 U/ml) and IgE levels (MF, GM
= 101 ng/ ml: CP, GM = 120 ng/ ml) were similar between the
two groups.
Lymphocyte proliferation responses to filarial Ags among
MF individuals were significantly diminished compared with
CP subjects (Table I; P < 0.05). This Ag-specific immune
“unresponsiveness” in MF individuals was restricted to filarial
antigens as the mean PPD-driven T cell proliferation was simi-
lar in the two groups (MF, GM stimulation index [ S.I.] = 14;
CP, GM S.I. = 34; P = 0.32).
Enhanced Fo of IL-4 relative to IFN- g secreting lympho-
cytes in MF vs. CP subjects. Because T cell proliferation is a late
and restricted indicator of T cell behavior, we examined an-








IgE indices to BmA
MF(n = 12)
CP(N = 17)
yr no./ml µg/ml mg/ml ng/ml
30(21-39) 414(78-960)* 48(13-132)‡ 1.300 (940-1,540)§ 2.724 (796-7.560)§ 2.2 (0.8-6.6)||
40(24-65) 0 0.2 (0-71) 2.009 (1.510-2.550) 859(97-8.200) 48(3.8-770)
* Geometric means (range).‡ P < 0.001 compared with CP.§ P < 0.01 compared with CP.|| P < 0.05 compared with CP.
other measure of immune response to specific antigens, that of
cytokine production. Because of the low frequency of antigen-
reactive T cells and the ephemeral nature of IL-4 in culture
supernatants, cytokine production by individual lymphocytes
was examined by ELISPOT. The geometric mean Fo of cells
secreting IL-4 in response to BmA ( 1: 11,730) were similar
   among MF subjects compared to CP individuals (GM
= 1:29,400: P = 0.08) (Fig. 1 A). In contrast, BmA-driven
IFN- g -secreting lymphocytes w re significantly diminished
among MF individuals (GM = 1:39,340) relative to GP sub-
jects (GM = 1:4,230: P < 0.0 1) (Fig. 1 B). Thus, though MF
and CP individuals showed similar Fo of IL-4-secreting cells in
response to filarial antigen, the relatively low Fo of IFN- g -
secreting lymphocytes from MF compared with CP subjects
indicated that the ratios of Ag-driven IL-4 to IFN- g -secreting
lymphocytes in the PBMC were distinctly different in the two
clinical groups. MF patients averaged eightfold greater Fo of
IL-4- to IFN- g -secreting cells (Fig. 1C), whereas the numbers
of WV-y-secreting lymphocytes exceeded that of IL-4-secret-
ing cells among most CP subjects.
The increased ratio of IL-4 to IFN- g -secreting cells was
restricted to filarial antigens. The Fo of PPD-driven IFN- g -
secreting lymphocytes was equivalent for MF and CP subjects
(GM = 1:5,710; range. 1:2,370-12,050; and GM = 1:3,944;
range, 1:917-47,170, respectively; P = 0.2) and PPD induced
rare IL-4-secreting lymphocytes with a Fo that was also not
significantly different between the two groups (CP, GM = 1:9
x 106; and MF, GM = 1:3.3 X 106; P = 0.31).
Figure 1. Frequency of Ag-reac-
tive lymphocytes in PBMC se-
creting IL-4 (A) or IFN- g (B),
or the ratio of the frequencies
(C) from patients with CP and
MF. Each point represents one
individual and the horizontal
IL-10 and TGF-ß mRNA levels in MF vs. CP individuals.
In addition to IL-4, IL-10 has also beenassociated with a T
helpe  type 2 (Th2) pattern of cytokine production in murine
m dels of helminth infection and correlates with downregula-
tion of Th 1 responses ( 16, 26-28). Although a more ubiqui-
tously produced cytokine than IL-10. TGF-ß also suppresses
lymphocyte proliferation ( 17). To examine whether MF sub-
jects produced more IL-10 and/or TGF-ß compared with CP
individuals. mRNA levels were measured in filarial Ag-stimu-
lated PBMC. IL-10 mRNA transcripts were present in five of
five MF subjects studied. whereas comparatively little IL-10
production occurred in CP individuals (Fig. 2). This difference
was statistically significant based on a comparison of the ratio
of IL-10 to HPRT density units, (CP, mean = 0.11±.01 vs.
MF, mean = 0.57±0.31; P < 0.01). Ag-induced TGF-ß mRNA
was present in four of five MF individuals and in two of the
four CP individuals examined (data not shown).
IL-IO and TGF-ß suppress Ag-driven T cell proliferation
responses in MF and not CP subjects. Since IL- 10 production
was preferentially elevated among MF subjects compared with
CP individuals and a principal action of this cytokine is to
inhibit antigen-driven lymphocyte proliferation (27-29), the
role of IL- 10 in mediating the Ag-specific “defect” in prolifera-
tive response seen in MF was examined in the presence of neu-
tralizing Ab to IL-10. Anti-IL-10 significantly augmented by
220-1,300% BmA-driven T cell proliferation in 7 of 10 MF
patients, whereas it had no effect on T cell proliferation in the
11 CP subjects studied (P < 0.01; Fig. 3, left). Note the overall
Figure 2. Levels of IL-10 and HPRT mRNA in parasite antigen-
driven PBMC from individuals with CP or MF. The ratio of denisto-
metric units for IL-10 and HPRT mRNA is shown below each indi-
viduals’ autoradiographs.
diminished T cell proliferative response in MF (vis-a-vis CP
subjects) as evidenced by the different scales on the y-axis in
Fig. 3. Although T cell proliferation was augmented in most
MF subjects in the presence of neutralizing IL-10 antibody,
even the enhanced proliferation among MF subjects generally
remained below that of the CP patients.
TGF-ß mRNA levels were also elevated in two MF subjects
and may also contribute to the modulation of lymphocyte pro-
liferation responses (17). In parallel experiments, neutralizing
anti-TGF-ß Ab added to cell cultures also significantly aug-
mented, although to a lesser degree. Ag-driven T cell prolifera-
tion in PBMC from 5 of 10 individuals with MF, but caused no
enhanced response by T cells of CP individuals (P < 0.05)
(Fig. 1).
The effect of neutralizing anti-IL-2 and anti-IFN- g antibod-
ies on T cell proliferation in both groups was studied in parallel
to that of anti-IL-10 and anti-TGF-ß. Neutralizing anti-IL-2
Abs significantly- inhibited Ag-driven T cell proliferation in 3 of
10 MF and 8 of 11 CP subjects. Neutralizing anti-IFN- g Ab
had no consistent effect on T lymphocyte proliferation in ei-
ther group (data not shown ).
Discussion
Impaired lymphocyte proliferation responses to filarial anti-
gens have been consistently observed in individuals with circu-
lating MF compared with amicrofilaremic subjects (4, 5, 11,
12). The recent understanding that lymphocytes produce a
broad array of cytokines that may influence the pattern of host
responses suggested further study of cytokine production in
filarial infections. The present study demonstrates that MF in-
dividuals possess filarial Ag-reactive lymphocytes that respond
fully to filarial antigens; their response, however, was primarily
in IL-4 production (and not IFN- g secretion). This contrasted
with the more immunologically responsive CP individuals,
who had a greater number of As-driven IFN- g -secreting cells
PATIENTS
Figure 3. Effect of neutralizing anti-IL-10 and anti-TGF-ß Abs on parasite Ag-driven T cell proliferation. Each paired set of bars represents an
individual’s mean (=SD ) net parasite Ag-  driven proliferation (cpm) oftriplicate cultures in the presence of the appropriate control Abs or with
anti-IL-10 Ab (left) or anti-TGF-ß Ab (right). Asterisks represent values that are significantly different from controls (P < 0.05).
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relative to IL-4. This pattern of cytokine production was re-
stricted to filarial antigens as the Fo of IL-4- and IFN- g -
secreting cells to the nonparasite Ag, PPD, were equivalent
between the two groups. The predominant IL-4 response to
filarial Ags and elevated serum levels of polyclonal IgE and
filarial-specific IgG4 suggests a Th2-like pattern of cytokine
production. In contrast. the increased numbers of filarial Ag-
specific IFN- g -secreting cells. strong lymphocyte proliferation
responses. and previous observations of enhanced IL-2 produc-
tion (relative to MF subjects in response to filarial Ags [14])
demonstrated a Th1-like pattern of cytokine synthesis among
symptomatic, amicrofilaremic individuals (CP). Thus, the im-
paired lymphocyte proliferation among MF subjects results not
from a lack of Ag-reactive lymphocytes, but from a pattern of T
cell activation that generates cytokines (increased IL-4 and di-
minished IFN- g ), which promotes humoral responses and not
lymphocyte proliferation.
Although less potent than IL-2, IL-4 also induces T cell
proliferation (30), and the almost complete absence of T cell
blastogenesis in some MF subjects observed in the present and
previous studies (4, 5, 11) suggested downmodulation of the
Th1 response. To address this question two cytokines that sup-
press lymphocyte proliferation were examined: IL-10 and
TGF-ß (17, 27-29). Ag-driven IL-10 mRNA levels were
clearly elevated in MF compared with CP individuals. Al-
though Ag-induced TGF-ß mRNA levels were elevated in 80%
of MF vs. 50% of CP subjects, the number of individuals stud-
ied was too small to draw any conclusions about significant
differences between the two groups. More importantly, neutral-
izing Abs to IL- 10 and TGF-ß significantly enhanced Ag-speci-
fic lymphocyte proliferation among MF and not CP subjects,
indicating that these cytokines contribute to a component of
active downmodulation. Whether IL-4 also contributes to this
cross-regulation is currently being investigated.
The principal subpopulation of PBMC responsible for in-
creased IL-10 production by MF subjects remains to be de-
fined, however, recent studies in normal human PBMC suggest
monocytes are a major source of IL-10 (27). Indeed, monocyte
(or B cell) -derived IL-10 could account for the findings in a
previous study in brugian filariasis demonstrating that deple-
tion of adherent cells from PBMC can partially reverse the
impaired T cell proliferation in MF subjects (8). The mecha-
nism of this IL-10 suppression of lymphocyte proliferation
likely occurs by inhibiting APC expression of MHC II (28) or
certain molecules such as B7/BB1 necessary for T cell activa-
tion (31).
Recently, in a study of a clinically similar group of MF
subjects (S. Mahanty, unpublished observations), neutralizing
Ab to IL-10 failed to augment Ag-specific IL-4 or IFN- g pro-
duction, although in this set of patients lymphocyte prolifera-
tion to parasite Ag tended to be roughly twofold greater than
that observed in the present study. Clearly, the precise role that
IL-10 plays in suppressing lymphocyte responses in MF sub-
jects remains to be fully defined. Nevertheless. modulation of
lymphocyte responses in patients with MF are likely to be mul-
tifactorial with a predominant Th2 response to filarial Ags con-
tributing the major component. Active downmodulation by
cross-regulatory cytokines such as IL-10 and TGF-ß may con-
tribute both to an Ag-specific component (T cell-derived IL-
10) and an Ag-nonspecific component (APC-derived IL-10
and TGF-ß).
Th  relative expression of filarial antigen-driven IFN- g a d
IL 4 secretion by individual lymphocytes appears to mirror the
clinical spectrum of response in lymphatic filariasis. The down-
regula ion of IFN- g production and lymphocyte proliferation
in MF subjects may diminish induction of cellular effectors
that contribute to the pathology of the disease and facilitate
removal of the microfilariae. In addition, enhanced IL-4 syn-
thesis generates strong humoral response,. particularly polyclo-
nal IgE, that may facilitate persistence of infection through the
production of irrelevant ( not parasite Ag-specific) IgE that satu-
rates hi h affinity IgE receptors expressed on mast cells and
renders them unable to be specifically cross-linked by parasite
antigen.
The presence of strong Th2 responses to helminth infec-
tions has been well established in murine models of Schisto-
soma mansoni (32), Nippostrongylus brasilensis (33), Helig-
mosomoides polygyrus (34), and Strongyloides venezuelensis
(35). The relative balance of cytokines associated with Th1
and Th2 subsets of CD4+ cells may determine the outcome of
th  host response to infections with Leishmania (36), Trichin-
ella (37), Schistosome (38), and Nippostrongylus species
(33). In murine models of schistosomiasis, the induction of a
Th2 response with egg deposition and associated suppression
of a Th1 response correlated with increased IL-10 production
(36). Similar to observations in the present study. addition of
eutralizing anti-IL-10 Ab to antigen-driven lymphocyte cul-
tures from schistosome-infected or (26) filarial-infected mice
(39) e hanced T cell proliferation and Th1 cytokine produc-
tion. These studies suggest an analogous immunomodulatory
rol  of IL-10 in murine models of helminth infections.
Profiles of cytokine responses in relation to the spectrum of
disease have also been examined in human schistosomiasis.
Human  with chronic schistosome infections are often asymp-
tomatic, have diminished granuloma size (40), and manifest
depressed antigen-specific T cell proliferation, IFN- g produc
tion, and IL-2 production along with augmented mitogen-dri-
ven IL-4 synthesis in culture supernatants of PBMC (41,42).
After sp cific chemotherapy for schistosomiasis, parasite Ag-
driven T cell proliferation (43), along with IFN- g and IL-2
Production by PBMC, increases significantly (41), thereby in-
dica ing a depressed Th1-like response during chronic infec-
tions.
The preferential induction of IL-4 relative to IFN- g produc-
tion (Th2-like response) in MF subjects may result from in
utero (or perinatal) exposure to parasite antigens or to antiidio-
type antibodies that render lymphocytes “unresponsive” to par-
asite antigens (as determined by lymphocyte proliferation).
Indirect evidence for prenatal sensitization has come from find-
ings that antifilarial antibodies of isotypes that do not cross the
lacent  (e.g., IgE and IgM) can be identified in the cord blood
of babies born to infected mothers (44) or in the cord sera of
babi s born in a region endemic for W. bancrofti (45). This
neonatally induced tolerance may be restricted to the Th1 sub-
se  whereas Th2 responses may escape the induction of toler-
ance, a possibility supported by recent studies in which alloan-
tigens given to neonatal mice resulted in donor-specific expan-
s of Th2 cells (46, 47). Thus, lymphocytes obtained from
infant cord blood or young children born from microfilaremic
mothers may preferentially produce IL-4 compared with IFN-
g or IL-2 in response to parasite antigen stimulation, in con-
trast to the offspring of amicrofilaremic mothers.
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Alternatively. the preferential induction of a Th2-like re-
sponse in MF subjects may result from peripheral tolerance.
This concept implies that a state of proliferative unresponsive-
ness is caused by an absence of a costimulatory signals from the
APC. Therefore, acquisition of infection in childhood may al-
low establishment the microfilaremic state, which, in turn,
leads to a high intravascular antigen load that saturates resting
B cells (or other APC [48]) or fails to induce costimulatory
ligands that could then lead to the preferential induction of
Th2 responses (49).
In the present study, we have demonstrated that MF sub-
jects respond to filarial Ags and produce cytokines (e.g., IL-4
IL-10, and TGF-ß) that have an antiinflammatory effect. Fur-
thermore. these data suggest that cytokine cross-regulation can
contribute to the impaired T cell proliferation observed among
MF subjects and may be diminished further by a relative de-
crease in the Fo IFN- g -secreting lymphocytes (and by infer-
ence IL-2-secreting cells) compared with IL-4-producing cells.
Most importantly, these data indicate that our definition of
tolerance should not be limited to the absence of Ag-reactive
proliferation of T cells but should be broadened to include the
notion that states of “specific immune unresponsiveness” may
be a reflection of an altered balance of immune reactivity.
Acknowledgments
We thank A. Maya, S. Usha, and S. Kumari for their technical assis-
tance throughout all aspects of this project. In addition, we thank Pat
Amato for help in preparation of the manuscript and Dr. James Kazura
for his thoughtful discussions and critical review of the paper.
The DNAX Research Institute is entirely supported by the Scher-
ing-Plough Corporation.
References
1. WHO Expert Committee on Filariasis 1984. Lymphatic filariasis. WHO
Tech. Report No. 702. Geneva. Switzerland. 7-107.
2. Ottesen. E A. 1980. Immunopathology of lymphatic filariasis in man.
Springer Semin. Immunopathol 2:373-385.
3. Ottesen. E.A., P. F. Weller, M. Lunde, and R. Hussain. 1982. Endemic
filariasis on a Pacific Island. II. Immunological aspects: Immunoglobulin. com-
plement and specific antifilarial IgG, IgM and IgE antibodies. Am. J. Trop. Med.
Hyg. 31:953-961.
4. Ottesen. E. A., P. F. Weller, and L. Heck 1977. Specific cellular immune
unresponsiveness in human filariasis. Immunology 33:413-421.
5. Piessens, W. F., P. B.McGreevy, P. W. Piessens, M. McGreevy, J. Koiman,
H. S. Sarsoso, and D. T. Dennis. 1980. Immune responses in human infections
with Brugia malayi. Specific cellular unresponsiveness to filarial antigens. J. Clin.
Invest. 65:172-179.
6. Weller, P. F., E. A. Ottesen, and L. Heck 1980. Immediate and delayed
hypersensitivity skin test responses to the Dirofilaria immitis filarial skin test
(Sawada) antigen in Wuchereria bancrofti filariasis. Am. J. Trop. Med. Hyg.
29:809-814.
7. Piessens, W. F., F. Partono, S. L. Hoffman, S. Tatiwayanto, P. W. Piessens,
J. R. Palmieri, J. Koiman, D. T. Dennis. and W. P. Carney. 1982. Antigen-speci-
fic suppressor T lymphocytes in human lymphatic filariasis. N. Engl. J. Med.
307:144-148.
8. Piessens, W. F., S. Ratiwaytano, S. Tuti, J. H. Palmeiri, P. W. Pieseens, J.
Koiman, and D. T. Dennis.  1980. Antigen-specificsuppressor cells and suppres-
sor factors in human filariasis with Brugia malayi. -N. Engl J. Med. 302:833-837.
9. Hussain. R. R, G. Hamilton, V. Kumaraswami, N. F. Adkinson, and E. A.
Ottesen. 1981. IgE response in human filariasis. I. Quantitation of filaria-specific
IgE. J. Immunol. 127:1623-1629.
10. McGreevy, P. B., S. Ratiwayanto, S, Tuti M. M, McGreevy. and D. T.
Dennis. 1980. Brugia malayi: Relationship between anti-sheath antibodies and
amicrofilaremia in native living in an endemic area of South Kalmantan. Bor-
neo. Am. J. Trop. Med. Hyg. 29:553-562.
11.  Nutman, T. B., V. Kumaraswami, and E. A. Ottesen. 1987. Parasite-speci-
1672. King et al.
tic an rgy in human filariasis. Insights after analysis of parasite antigen-driven
lymphokine production. J. Clin. Invest. 79:1516-1523.
12. King, C. L., V. Kumaraswami, R. W. Poindexter, S. Kumari, K. Jayara-
man, D. W. Alling,E. A. Ottesen. and T. B. Nutman. 1992. Immunologic toler-
ance in lymphatic filariasis: diminished parasite-specific T and B lymphocyte
precursor frequency in the microfilaremic state. J. Clin. Invest. 89:1403-1410.
13. Ottesen. E.A., F. Skvaril, S. P. Tripathy, R. W. Poindexter, and R. Hus-
sain. 1985. Prominence of IgG4 in the IgG antibody response to human filariasis.
J. Immunol. 134:2707-2712.
14. Nutman, T. B., V. Kumaraswami, L. Pao, P. R. Narayanan, and E. A.
Ottesen. 1987. An analysis of in vitro B cell immune responsiveness in human
lymphatic filariasis. J. Immunol. 138:3954-3959.
15. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin 10
inhibits macrophage microbicidal activity by blocking the endogenous produc-
tion of tumor necrosis factor alpha required as a costimulatory factor for inter-
feron gamma-induced activation. Proc.Natl. Acad. Sci. USA. 89:8676-8680.
16. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregu-
lation of Th1 and Th2 responses. Immunol. Today. 12:A49-53.23.
17. Sporn, M. B.. and A. B. Roberts. 1990. The transforming growth factor-ßs.
In Peptide Growth Factors and Their Receptors  I.M. B. Spom and A. B. Roberts,
editors. Springer Publishing Company. New York. 419-432.
16. Weller, P. F., and E. A. Ottesen. 1978. Failure of diethylcarbamazine as a
provocative test in subperiodic Wuchereria bancrofti filariasis. Trans. R. Soc.
Trop. Med. Hyg. 7:13-32.
19. Boyum, A. 1968. Separation of leukocytes from blood and bone marrow.
Scan. J. Clin. Lab. Invest 21 (Suppl. 97):77-89.
20. Hamilton. R. G., R. Hussain, E. A. Ottesen, and J. N. F. Adkinson. 1981
The quantitation of parasite-specific human IgG and IgE in sera: evaluation of
solid-phase RIA and ELISA methodology. J. Immunol. Methods. 44:101-114.
21. Mahanty. S,. J. S. Abrams, C. L. King, A. P. Limaye, and T. B. Nutman.
1992. Parallel regulation of IL-4 and IL-5 in human helminth infections J. Im-
munol. 148:3567-3571.
22. Chomczynski. P., and N. Sacchi. 1987. Single-step method of RNA isola-
tion by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Bio-
chem. 162:156-159.
23. Svetic, A., F. D. F. D. Finkelman, Y. C. Jian, C. W. Dieffenbach,. D. E.
Scott, K F. McCarthy, A. D. Steinberg. and W. C. Gause. 1991. Cytokine gene
expression after in vivo primary immunization with goat antibody to mouse IgD
antibody. J. Immunol. 147:2391-2397.
24. Karp, C. L., S. H. El-Safi, T. A. Wynn, M. M. H. Satti, A. M. Kordofani,
F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman. and D. L. Sacks 1993. In
vivo cytokine profiles in patients with kala-azar. Marked elevation of both IL-10
and interferon- g. J. Clin. Invest. 91:1644-1648.
25. King. C. L., E. A. Ottesen, and T. B. Nutman. 1990. Cytokine regulation
of antigen-driven immunoglobulin production in filarial parasite infections in
humans. J Clin. Invest. 85:1810-1815.
26. Sher. A., D. Fiorentino, P. Casper, E. Pearce. and T. Mosmann. 1991.
Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of
Thl cytokine synthesis in helminth infection. J. Immunol. 147:2713.
27. de Waal Malefyt, R. J. Abrams, B. Bennett, C. B. Figdor, and J. E. de
Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human mono-
cyt s: an autoregulatory role of IL-10 produced by monocytes. J. Exp. M d
174:1209-1220.
28. de Waal Malefyt. R., J. Haanen, H. Spits. M-G. Roncarolo, .A. Velde, C.
Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin
10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell prolifera-
tion by diminishing the antigen-presenting capacity of monocytes via downregula-
t on of class II major histocompatibility complex expression. J. Exp. Med.
174:915-924.
29. Fiorentino D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard,
K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting  cell to
inhibit cytokine production by Thl cells. J. Immunol 146:3444-3451.
30. Tan. P., C. Anasetti, J. A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw,
J. A. Ledbetter, and P. S. Linsley. 1993. Induction of alloantigen-specific hypore-
sponsiveness in human T lymphocytes by blocking interaction of CD28 with its
natural ligand B7 BB1. J Exp. Med. 177:165-173.
31 Ding. L., and E. M. Shevach. 1992. IL-10 inhibits mitogen-induced  T cell
proliferation by selectively inhibiting macrophage costimulatory function. J. Im-
munol. 148:3133-3139.
32. Sher.A., R. L. Coffman, S. Hieny, and A. W. Cheever. 1990. Ablation of
eosinophil and IgE responses with anti-IL-5 or anti-IL-l antibody fails to affect
immunity against Schistosoma mansoni in the mouse. J. Immunol 145:3911-
3916.
33. Finkelman. F. D., E. J. Pearce, J. J. Urban. and A. Sher. 1991. Regulation
and biological function of helminth-induced cytokine responses. Immunol. To-
ay 12:A62-A66.
34. Urban. J. J., I.M. Katona, W. M. Paul, and R. D. Finkelman. 1991.
I erleukin 4 is important; in protective immunity to a gastrointestinal nematode
infection in mice. Proc. Natl. Acad. Sci. USA. 88:5513-5517.
35. Korenaga. M., Y. Hitoshi, N. Yamaguchi, Y. Sato, K. Takatsu, and I.
Tada. 1991. The role of interleukin-5 in protective immunity to Strongyloides
venezuelensis nfection in mice. Immunology 72:502-507.
36. Heinzel. F. P., M. D. Sadick, B. J. Holaday, R. L Coffman, and R. M.
Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 4 dur-
ing the resolution or progression of murine leishmaniasis. Evidence for expansion
of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
37. Pond. L., D. L. Wassom, and C. E. Haves. 1989. Evidence for differential
induction of helper T cell subsets during Trichinella spiralis infection. J Im-
munol. 143:4232-4237.
38. Pearce. E. J., P. Caspar, J. M. Grzych, F. A. Lewis and A. Sher. 1991.
Downregulation of Th1 cytokine production accompanies induction of Th2 re-
sponses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173:159-
166.
39. Pearlman. E., F. E. Hazlett Jr.. W. H. Boom, and J. W. Kazura. 1993.
Induction of murine T-helper cell responses to the filarial nematode Brugia
malayi. Infect. Immun. 61:1105-1112.
40. Domingo E. 0., and K. S. Warren. 1968. Endogenous desensitization:
changing host granulomatous response to schistosome eggs at different stages of
infection with Schistosoma mansoni. Am. J. Pathol. 52:369-377.
41. Zwingenberger. K., E. Irschick, J. G. Siqueira Vergetti, A. R. Correia
Decal, R. Janssen-Rosseck, U. Bienzle, C. Huber, and H. Feldmeier. 1989. Re-
lease of interleukin 2 and gamma interferon by peripheral mononuclear cells in
human Schistosomiasis mansoni infection normalizes after chemotherapy.
Scand. J. Immunol. 30:463-471.
42. Zwingenberger. K., A. Hohmann, M. Cardoso de Brito, and M. Ritter.
1991. Impaired balance of interleukin-4 and interferon- g production in infec-
tions with Schistosomiasis mansoni and intestinal nematodes. Scand. J. Im-
munol. 34:243-251.
43. Colley. D. G., I. S. Barsoum, H. S. S Dahawi, F. Gamil, M. Habib, and
XI. .A. El Alamy. 1986. Immune responses and immunoregulation in relation to
human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in
vitro responsiveness after treatment. Trans. R. Soc. Trop. Med. Hyg. 80:952-957.
44. Weil, G. J., R. Hussain, V. Kumarawnmi, S. P. Tripathy, K. S. Phillips,
and E. A. Ottesen. 1983. Prenatal allergic sensitization to helminth antigens in
offspring of parasite-infected mothers. J. Clin. Invest. 71:1124-1129.
45. Sanjeevi, C. B., and P. R. Narayanan. 1989. Antifilarial and anti-PPD IgM
antibodies in cord blood. In ian J. Pediatr. 56:207-211.
46. Merino. J., S. Schurmans, M. A. Duchosal, S. Izui and P. H. Lambert.
1989. Autoimmune syndrome after induction of neonatal tolerance to alloanti-
gens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells. J.
Immunol. 143:2202-2208.
47. Goldman M., P. Druet, and E. Gleichmann. 1991. Th2 cells in systemic
autoimmunity: insights from allogeneic disease and chemically-induced autoim-
munity. Immunol. Today. 12:223-228.
48. Eynon, E E., and D. C. Parker. 1992. Small B cells as antigen-presenting
cells in the induction of tolerance to soluble protein antigens. J. Exp. Med.
175:131-138.
49. Chang, T., C. M. Sea. S. Urioste, R. C. Thompson, W.H. Boom, and A. K.
Abbas. 1990. Heterogeneity of helper/inducer T lymphocytes III. Responses IL-2
and IL-4-producing (Th1 and Th2) clones to antigens presented by different
accessory cells. J. Immunol. 145:2803-2808.
T Helper Type 2 Response in Human Lymphatic Filariasis1673
